Deregulation of tumor angiogenesis and blockade of tumor growth in PPARβ‐deficient mice
暂无分享,去创建一个
Wolfgang Meissner | Boris Keil | Jeffrey M Peters | Klaus J Klose | Kerstin Kaddatz | Sabine Müller-Brüsselbach | B. Keil | A. Burdick | R. Moll | J. Peters | R. Müller | W. Meissner | Rolf Müller | Martin Kömhoff | Roland Moll | M. Kömhoff | Markus Rieck | Jürgen Adamkiewicz | Andrew D Burdick | Markus Rieck | S. Müller-Brüsselbach | J. Adamkiewicz | K. Kaddatz | Klaus J Klose | Kerstin Kaddatz | Andrew D. Burdick | J. Peters
[1] Béatrice Desvergne,et al. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. , 2006, Progress in lipid research.
[2] Barry M. Forman,et al. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ , 1997 .
[3] T. Willson,et al. Ligand activation of peroxisome proliferator-activated receptor-β/δ(PPARβ/δ) inhibits cell growth of human N/TERT-1 keratinocytes , 2007 .
[4] T. Willson,et al. Peroxisome proliferator-activated receptor (PPAR)-beta/delta stimulates differentiation and lipid accumulation in keratinocytes. , 2004, The Journal of investigative dermatology.
[5] A. Krook,et al. Role of AMP Kinase and PPARδ in the Regulation of Lipid and Glucose Metabolism in Human Skeletal Muscle* , 2007, Journal of Biological Chemistry.
[6] A. Agarwal,et al. "Lumen digestion" technique for isolation of aortic endothelial cells from heme oxygenase-1 knockout mice. , 2004, BioTechniques.
[7] O. Sansom,et al. PPARdelta status and Apc-mediated tumourigenesis in the mouse intestine. , 2004, Oncogene.
[8] R. Evans,et al. PPAR delta: a dagger in the heart of the metabolic syndrome. , 2006, The Journal of clinical investigation.
[9] S. Nielsen,et al. Identification and localization of aquaporin water channels in human salivary glands. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[10] W. Wahli,et al. PPARβ/δ Regulates Paneth Cell Differentiation Via Controlling the Hedgehog Signaling Pathway , 2006 .
[11] R. Evans,et al. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. , 1998, Cell.
[12] Jasmine Chen,et al. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[13] P. Kristjansen,et al. Angiogenic synergy of bFGF and VEGF is antagonized by Angiopoietin-2 in a modified in vivo Matrigel assay. , 2004, Microvascular research.
[14] J. Massagué,et al. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. , 1995, Genes & development.
[15] M. Tomayko,et al. Determination of subcutaneous tumor size in athymic (nude) mice , 2004, Cancer Chemotherapy and Pharmacology.
[16] Gavin Thurston,et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis , 2006, Nature.
[17] Daniel Metzger,et al. Impaired skin wound healing in peroxisome proliferator–activated receptor (PPAR)α and PPARβ mutant mice , 2001, The Journal of cell biology.
[18] M. Knopp,et al. Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging , 2003, Journal of magnetic resonance imaging : JMRI.
[19] W. Wahli,et al. Transcriptional regulation of metabolism. , 2006, Physiological reviews.
[20] Y. Yoon,et al. Intramyocardial Transplantation of Autologous Endothelial Progenitor Cells for Therapeutic Neovascularization of Myocardial Ischemia , 2003, Circulation.
[21] T. Willson,et al. Ligand activation of peroxisome proliferator-activated receptor beta inhibits colon carcinogenesis. , 2006, Cancer research.
[22] S. Okret,et al. p57Kip2, a glucocorticoid-induced inhibitor of cell cycle progression in HeLa cells. , 1999, Molecular endocrinology.
[23] R. Evans,et al. Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Folkman. Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.
[25] A. Burdick,et al. The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). , 2006, Toxicological sciences : an official journal of the Society of Toxicology.
[26] D. Nettelbeck,et al. Cell type specificity of the human endoglin promoter. , 1999, Gene.
[27] K. Kristiansen,et al. Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid. , 2001, The Journal of investigative dermatology.
[28] P. Carmeliet. Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.
[29] R. Evans,et al. PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL , 1998, Cell.
[30] P. Schlag,et al. Transient expression of SV 40 large T antigen by Cre/LoxP-mediated site-specific deletion in primary human tumor cells. , 1997, Human gene therapy.
[31] Minhong Yan,et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis , 2006, Nature.
[32] A. Burdick,et al. The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation. , 2006, Cellular signalling.
[33] T. Willson,et al. PPARbeta/delta selectively induces differentiation and inhibits cell proliferation. , 2006, Cell death and differentiation.
[34] P. Bornstein,et al. Thrombospondins 1 and 2 function as inhibitors of angiogenesis. , 2003, Matrix biology : journal of the International Society for Matrix Biology.
[35] J. Ward,et al. Growth, Adipose, Brain, and Skin Alterations Resulting from Targeted Disruption of the Mouse Peroxisome Proliferator-Activated Receptor β(δ) , 2000, Molecular and Cellular Biology.
[36] Rajnish A. Gupta,et al. Activation of nuclear hormone receptor peroxisome proliferator–activated receptor-δ accelerates intestinal adenoma growth , 2004, Nature Medicine.
[37] W. Wahli,et al. Critical roles of PPARβ/δ in keratinocyte response to inflammation , 2001 .
[38] Gavin Thurston,et al. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. , 2006, Nature.
[39] W. Wahli,et al. Critical roles of PPAR beta/delta in keratinocyte response to inflammation. , 2001, Genes & development.
[40] R. Evans,et al. PPARδ: a dagger in the heart of the metabolic syndrome , 2006 .
[41] A. Burdick,et al. The role of peroxisome proliferator-activated receptor-beta/delta in epithelial cell growth and differentiation. , 2006, Cellular signalling.
[42] T. Willson,et al. PPARβ/δ selectively induces differentiation and inhibits cell proliferation , 2006, Cell Death and Differentiation.
[43] Bert Vogelstein,et al. Genetic disruption of PPARδ decreases the tumorigenicity of human colon cancer cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[44] W. Stadler. Gemcitabine doublets in advanced urothelial cancer. , 2002, Seminars in oncology.
[45] J. Ntambi,et al. Peroxisome proliferators induce mouse liver stearoyl-CoA desaturase 1 gene expression. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[46] Mina J. Bissell,et al. Putting tumours in context , 2001, Nature Reviews Cancer.
[47] S. Chien,et al. Laminar Flow Activates Peroxisome Proliferator–Activated Receptor-&ggr; in Vascular Endothelial Cells , 2004, Circulation.
[48] K. Kinzler,et al. Genetic disruption of PPARdelta decreases the tumorigenicity of human colon cancer cells. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[49] J. McLauchlan,et al. A PPAR response element regulates transcription of the gene for human adipose differentiation-related protein. , 2005, Biochimica et biophysica acta.
[50] M. Kreutzer,et al. Induction of PPARβ and prostacyclin (PGI2) synthesis by Raf signaling: failure of PGI2 to activate PPARβ , 2006 .
[51] T. Nakajima,et al. Fenofibrate, a peroxisome proliferator‐activated receptor α agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver , 2006, Liver international : official journal of the International Association for the Study of the Liver.
[52] Fabian Kiessling,et al. Comparing Dynamic Parameters of Tumor Vascularization in Nude Mice Revealed by Magnetic Resonance Imaging and Contrast‐Enhanced Intermittent Power Doppler Sonography , 2003, Investigative radiology.
[53] B. Teicher,et al. Murine Endothelial Cell Lines as Models of Tumor Endothelial Cells , 2004, Clinical Cancer Research.
[54] T. Willson,et al. Ligand activation of peroxisome proliferator-activated receptor-beta/delta(PPARbeta/delta) inhibits cell growth of human N/TERT-1 keratinocytes. , 2007, Cellular signalling.
[55] W. Wahli,et al. PPARbeta/delta regulates paneth cell differentiation via controlling the hedgehog signaling pathway. , 2006, Gastroenterology.
[56] Tasuku Honjo,et al. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. , 2004, Genes & development.
[57] T. Willson,et al. Peroxisome Proliferator-Activated Receptor (PPAR)-β/δ Stimulates Differentiation and Lipid Accumulation in Keratinocytes , 2004 .
[58] M. Andreeff,et al. Differential tumor suppressor properties and transforming growth factor-β responsiveness of p57KIP2 in leukemia cells with aberrant p57KIP2 promoter DNA methylation , 2007, Oncogene.
[59] Marios C. Papadopoulos,et al. Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption , 2005, Nature.
[60] Stephen P. H. Alexander,et al. Peroxisome proliferator activated , 2006 .
[61] J. Peters,et al. Peroxisome Proliferator-activated Receptor-β/δ Inhibits Epidermal Cell Proliferation by Down-regulation of Kinase Activity* , 2005, Journal of Biological Chemistry.
[62] O. Sansom,et al. PPARδ status and Apc-mediated tumourigenesis in the mouse intestine , 2004, Oncogene.
[63] S. Elledge,et al. Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome , 1997, Nature.
[64] J. Ward,et al. Peroxisome proliferator-activated receptor-delta attenuates colon carcinogenesis. , 2004, Nature medicine.
[65] O. Sato,et al. Dual Promoter Structure of Mouse and Human Fatty Acid Translocase/CD36 Genes and Unique Transcriptional Activation by Peroxisome Proliferator-activated Receptor α and γ Ligands* , 2002, The Journal of Biological Chemistry.
[66] William A. Boisvert,et al. Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ , 2003, Science.
[67] W. Wahli,et al. Differentiation of Trophoblast Giant Cells and Their Metabolic Functions Are Dependent on Peroxisome Proliferator-Activated Receptor β/δ , 2006, Molecular and Cellular Biology.
[68] O. Sato,et al. Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands. , 2002, The Journal of biological chemistry.